October synopsis: The latest in Praxis and clinical research news.

In this month’s synopsis, learn about digital news sources within the pharmaceutical industry, updates from the SCOPE conference, influential leaders in the industry, little-known clinical trial facts, and more.

The latest from Praxis.

Staying up-to-date on industry news is important to us. We keep a finger on the pulse of industry news with our favorite digital news sources.

We’re honored to have attended and participated in the first European Summit for Clinical Operations Executives (SCOPE) conference, but our conference involvement in October didn’t stop there.

When we think of influential leaders in our industry, certain names and companies come to mind. What would pharmaceuticals be without these main players?

We’ve gone back to the very beginning and promise to bring you all the way through to modern day with these interesting facts about clinical trials.

Elsewhere in the news.

Clinical research and its advancement lie in the hands of dedicated research participants. Our very own Karen Renzi is highlighted for sharing her thoughts about eliminating nonadherence in participants.

Data is collected, sold, and bought without second thought. Is that really the way it should be? An app can give you a title or deed of your patient information, and it could be a game changer.

Stay up-to-date on all the latest from Praxis on our blog, and be sure to check us out on Facebook, Twitter, and LinkedIn.

Any questions? Want to know more?

Contact us today.